AnaptysBio
ANAB
ANAB
121 hedge funds and large institutions have $457M invested in AnaptysBio in 2019 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 47 increasing their positions, 19 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.13% less ownership
Funds ownership: 107.36% → 104.23% (-3.1%)
32% less call options, than puts
Call options by funds: $7.83M | Put options by funds: $11.5M
55% less capital invested
Capital invested by funds: $1.02B → $457M (-$559M)
Holders
121
Holding in Top 10
3
Calls
$7.83M
Puts
$11.5M
Top Buyers
| 1 | +$31.9M | |
| 2 | +$30M | |
| 3 | +$21.1M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$16.3M |
Top Sellers
| 1 | -$94.3M | |
| 2 | -$87.6M | |
| 3 | -$63.1M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$42.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$30.2M |